CME Group Inc. (CME)
CME Group Inc. (CME) Q3 2024 Earnings Call Transcript
CME Group Inc. (NASDAQ:CME ) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Adam Minick - Head of IR Terrence Duffy - Chairman, CEO Lynne Fitzpatrick - CFO Suzanne Sprague - Senior Managing Director, Global Head of Clearing Julie Winkler - CCO Mike Dennis - Global Head of Fixed Income Tim McCourt - Senior Managing Director, Global Head of Financial Derek Sammann - Senior Managing Director, Global Head of Commodities Conference Call Participants Dan Fannon - Jefferies Chris Allen - Citi Ben Budish - Barclays Ken Worthington - JP Morgan Patrick Moley - Piper Sandler Alex Kramm - UBS Kyle Voigt - KBW Brian Bedell - Deutsche Bank Craig Siegenthaler - Bank of America Owen Lau - Oppenheimer Michael Cyprys - Morgan Stanley Bill Katz - TD Cowen Operator Welcome to the CME Group Third Quarter 2024 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
CME (CME) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Tops Q3 Earnings and Revenue Estimates
CME Group (CME) came out with quarterly earnings of $2.68 per share, beating the Zacks Consensus Estimate of $2.65 per share. This compares to earnings of $2.25 per share a year ago.
Can CME Group Retain its Beat Streak This Earnings Season?
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Countdown to CME (CME) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of CME (CME) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pockets Of Value On The Long Side Despite Markets Sitting Near All-Time Highs
Added new longs: CME Group, CompoSecure, and Mitsubishi Heavy Industries during early August market dip; exited Finning and reduced Garmin and Kongsberg due to full valuations. CME Group is undervalued with strong potential due to its monopoly-like position in derivatives markets and resilience against new competition. CompoSecure benefits from a transformative transaction with David Cote, enhancing financial structure and strategic direction, making shares attractive despite prior SPAC stigma.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CME Group: An Interesting Option For Every Dividend Investor
CME Group's dominant market position and high profitability make it a crucial player in global finance, particularly in derivatives and futures trading. The company's exceptional free cash flow margin of 60.30% and consistent dividend growth make it an attractive option for dividend investors. Despite its strong fundamentals, CME Group is currently rated as a hold due to its high valuation, with a fair value estimate of $211.27 per share.
10-year Treasury yield rebounds back above 4%
U.S. Treasury yields were slightly higher early Monday as investors assessed future moves from the Federal Reserve following Friday's bumper jobs report.
Final Trades: Nvidia, Trade Desk Inc and CME Group.
Here's today's Final Trades from the Investment Committee.
CME Stock Trading at Discount to Industry at 22.46X: Should You Buy?
Solid global presence, a compelling product portfolio, increased electronic trading and a focus on over-the-counter clearing services poise CME Group for growth.
